Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis

Anticancer Research

Volumn 23, Issue 4, 2003, Pages 3333-3339

  Chew, Boon P ^a   Brown, Cynthia M ^a   Park, Jean Soon ^a   Mixter, Philip F ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Apoptosis; Gene regulation; Lutein; Mammary; Mice; Tumor

Indexed keywords

ANNEXIN; FLUORESCEIN ISOTHIOCYANATE; PROTEIN BAX; PROTEIN BCL 2; XANTHOPHYLL;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DIET SUPPLEMENTATION; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; INOCULATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DIVISION; DIET; EATING; FEMALE; LUTEIN; LYMPHOCYTES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0041528182     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Park JS, Chew BP and Wong TS: Dietary lutein from marigold extract inhibits mammary tumor development in BALB/c mice. J Nutr 128: 1650-1656, 1998.
2. Chew B, Wong MW and Wong TS: Effects of lutein from marigold extract on immunity and growth of mammary tumors in mice. Anticancer Res 17: 3689-3694, 1996.
3. Cerveny CG, Chew BP, Park JS and Wong TS: Dietary lutein inhibits tumor growth and normalizes lymphocyte subsets in tumor-bearing mice. FASEB J 13: A210, 1999.
4. Sumatran VN, Zhang R, Lee DS and Wicha MS: Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid. Cancer Epid Biomarkers Prev 9: 257-263, 2000.
5. Folkman J: Towards an understanding of angiogenesis: search and discovery. Perspect Biol Med Autumn 29 (1): 10-36, 1985.
6. Konkel ME and Mixter PF: Flow cytometric detection of host cell apoptosis induced by bacterial infection. Meth Cell Sci 22: 209-215, 2000.
7. McCarthy RC and Fetterhoff TJ: Issues for quality assurance in clinical flow cytometry. Arch Path Lab Med 113: 658-666, 1989.
8. Hansbrough FF, Soderberg C, Field TO Jr, Swisher S, Brahme J, Zapata-Sirvent RL, Tonks M and Gadd MA: Analysis of murine lymphocyte subpopulations by dual-color flow cytometry: technical considerations and specificities of monoclonal antibodies directed against surface markers. J Surg Res 44: 121-136, 1988.
9. Leers MPG, Kolgen W, Bjorklaund V, Bergman T, Tribbick G, Persson B, Bjorklund P, Ramaekers FCS, Bjorklund B, Nap M, Jornvall H and Schutte B: Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Path 187: 567-572, 1999.
10. Fox SB and Harris AL: Markers of tumor angiognesis: Clinical applications in prognosis and anti-angiogenic therapy. Invest New Drugs 15: 15-28, 1997.
11. Vanzulli S, Gazzaniga S, Braidot MF, Vecchi A, Mantovani A and Wainstock de Calmanovici R: Detection of endothelial cells by MEC 13.3 monoclonal antibody in mice mammary tumors. BioCell 21(1): 39-46, 1997.
12. Kanangat S, Solomon A and Rouse BT: Use of quantitative polymerase chain reaction to quantitate cytokine messenger RNA molecules. Molec Immunol 29 (10): 1229-1236, 1992.
13. O'Driscoll L, Daly C, Saleh M and Clynes M: The use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells. Cytotechnology 12: 289-314, 1993.
14. SAS: SAS/STAT@ User's Guide: SAS Inst. Inc., Cary, NC, 1991.
15. Schwartz JL and Shklar G: Retinoid and carotenoid angiogenesis: A possible explanation for enhanced oral carcinogenesis. Nutr Cancer 27: 192-199, 1997.
16. Chew BP and JS Park: Carotenoid action on the immune response. J Nutr 132, 2002 (in press).
17. Park JS, Chew BP, Wong TS, Zhang JX and Magnuson NS: Dietary lutein but not astaxanthin or β-carotene increases Pim-1 gene expression in murine lymphocytes. Nutr Cancer 33: 206-212, 1999.
18. Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, van Wezenbeek P, Melief C and Berns A: (1984) Murine leukemia virus-induced T-cell lympomagenesis: integration of proviruses in a distinct chromosomal region. Cell 37: 141-150, 1984.
19. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
20. Steele RJC, Thompsom AM, Hall PA and Lane DP: The p53 tumour suppressor gene. Brit J Surgery 85: 1460-1467, 1998.
21. Miyashita T, Krajewski S and Wang HG: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.22.
22. Gottlieb RA: Mitochondria: execution central. Febs Lett 482: 6-12, 2000.
23. Ames, BN, Shigenaga MK and Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90: 7915-7922, 1993.
24. Flescher E, Ledbetter JA, Schieven GL, Vela-Roch N, Fossum D, Dang H, Ogawa N and Talal N: Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J Immunol 153: 4880-4889, 1994.
25. Mendelson KG, Contois L-R and Tevosian GG: Independent regulation of JNK/p38 MAP kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci USA 93: 12908-12913, 1996.
26. van den Broek ME, Kagi D, Ossendorp F, Toes R, Vamvakas S, Lutz WK, Melief CJ, Zinkernagel RM and Hengartner H: Decreased tumor surveillance in perforin-deficient mice. J Exp Med 184: 1781-90, 1996.